Wird geladen...
Autoimmunity, Checkpoint Inhibitor Therapy and Immune-related Adverse Events: A Review
Immune checkpoint inhibitors have emerged as a remarkable treatment option for diverse cancer types. However, a significant number of patients on checkpoint inhibitors develop immune-related adverse events (irAEs) affecting a wide variety of organs. These events, which may reflect enhanced T cell ac...
Gespeichert in:
| Veröffentlicht in: | Semin Cancer Biol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6980444/ https://ncbi.nlm.nih.gov/pubmed/31330185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semcancer.2019.06.012 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|